Editing the Genome to Cure Genetic Disease

Casebia combines CRISPR/Cas9 expertise and technology from CRISPR Therapeutics with access to deep disease-state knowledge and protein engineering capabilities from Bayer. Our aim: to transform the lives of patients and families affected by genetic disease.

Social Media

#MotivationMonday: Moving blog from our collaborator @SeattleChildren’s Research Institute on a 7-year-old boy named Sonny battling a rare #autoimmune disorder called IPEX syndrome. Stories like Sonny's inspire us to advance new #geneediting therapeutics. https://t.co/dAnOYgicYe

Our own Shyam Subramanian will speak at #NEXTGENCART on the topic of “Developing Manufacturing Platforms for Complex #GeneEdited #Tcell Therapies for #AutoimmuneDisease” based on our work with @SeattleChildren’s Research Institute via @AntibodyEng365 https://t.co/bfpsu8z1WP

See us on Twitter